Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo Evaluation
the intra-tumoral administration of the IPHRLI formulation may provide a potential strategy for breast cancer management.
Authors
- Doaa S. Hamad
- Ahmed H.E. Hassan (ORCID: https://orcid.org/0000-0002-1048-6281)
- Samar F. Miski (ORCID: https://orcid.org/0000-0001-7136-7537)
- Amany Belal (ORCID: https://orcid.org/0000-0003-1045-0163)
- Safaa Khalil (ORCID: https://orcid.org/0000-0002-0588-3266)
- Marwa M. Nagib (ORCID: https://orcid.org/0000-0002-4508-9497)
- Gi-Hui Kim
- Amr Gamal Fouad (ORCID: https://orcid.org/0000-0002-0082-4160)
- Shatha Hallal Al-Ziyadi
- Hanan O. Farouk (ORCID: https://orcid.org/0000-0001-8272-3189)
- Kyung‐Tae Lee (ORCID: https://orcid.org/0000-0002-3141-3727)
- Demiana M. Naguib
- Nisreen Khalid Aref Albezrah
Institutions
- Beni-Suef University (EG)
- Mansoura University (EG)
- Taif University (SA)
- Taibah University (SA)
- Nahda University (EG)
- Kyung Hee University (KR)
- Misr International University (EG)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-11-11
- DOI
- https://doi.org/10.3390/ph17111518
- Citations
- 5
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.87
Funders
- Taif University